key: cord-0769019-3t5be1ni
authors: Borges, V.; Isidro, J.; Macedo, F.; Neves, J.; Silva, L.; Paiva, M.; Barata, J.; Catarino, J.; Ciobanu, L.; Duarte, S.; Vieira, L.; Guiomar, R.; Gomes, J. P.
title: Nosocomial outbreak of SARS-CoV-2 in a 'non-COVID-19' hospital ward: virus genome sequencing as a key tool to understand cryptic transmission
date: 2021-02-23
journal: nan
DOI: 10.1101/2021.02.20.20248421
sha: 629e27a2ca74394bdd31c5b5878d7bf212f5c3d0
doc_id: 769019
cord_uid: 3t5be1ni

Background. Dissemination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in healthcare institutions affects both patients and health-care workers (HCW), as well as the institutional capacity to provide essential health services. Methods. We conducted an investigation of a cluster of SARS-CoV-2 positive cases detected in a 'non-COVID-19' hospital ward during Summer 2020. The magnitude of the nosocomial outbreak was disclosed by massive testing, challenging the retrospective reconstruction of the introduction and transmission events. An in-depth contact tracing investigation was carried out to identify the contacts network during the 15-day period before the screening. In parallel, positive SARS-CoV-2 RNA samples were subjected to virus genome sequencing. Results. Of the 245 tested individuals, 48 (21 patients and 27 HCWs) tested positive for SARS-CoV-2. HCWs were mostly asymptomatic, but the mortality among the vulnerable patient group reached 57.1% (12/21). Phylogenetic reconstruction revealed that all cases were part of the same transmission chain, thus confirming a single origin behind this nosocomial outbreak. By combining vast epidemiological and genomic data, including analysis of emerging minor variants, we unveiled a scenario of silent SARS-CoV-2 dissemination within the hospital ward, mostly driven by the close contact within the HCWs group and between HCWs and patients. This investigation triggered enhanced prevention and control measures, leading to a more timely detection and containment of novel nosocomial outbreaks. Conclusions. The present study shows the benefit of combining genomic and epidemiological data for the investigation of complex nosocomial outbreaks, and provides valuable data to minimize the risk of transmission of COVID-19 in healthcare facilities.

The pandemic coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), the causative agent of COVID-19 [1, 2] , is a highly contagious respiratory virus that has rapidly spread globally, having caused more than 105 million reported cases and 2.3 million deaths, as of 13 February 2020 [3] . The clinical presentation of COVID-19 ranges from asymptomatic or mild symptomatic infections to severe respiratory symptoms, multiorgan failure or death, which is more frequent in elderly generally presenting comorbidities [1, 2, 4] .

SARS-CoV-2 transmission within healthcare institutions is of utmost public health concern at global level [5] [6] [7] [8] , with several studies reporting high infection rates among healthcare workers (HCW) and/or hospitalized patients [9] [10] [11] [12] [13] . Nosocomial COVID-19 outbreaks can have a tremendous negative impact at individual health level, such as detrimental effects on HCW well-being and increased morbidity and mortality among patients. Also, at community level, they implicate the loss of institutional capacity, namely staff and resources, to provide non-COVID-19 and COVID-19 clinical assistance to the community. In this context, several recommendations have been launched by national and international health authorities [5, 6] to place robust preventive (e.g., guarantee sufficient supplies of personal protective equipment; promote routine testing among HCW) and control measures to timely detect and limit SARS-CoV-2 transmission within healthcare institutions. With the recent advances in sequencing technologies, it is now possible to strengthen outbreak investigations by performing timely virus genome sequencing [10, [14] [15] [16] . This tool can be key not only to detect and reconstruct nosocomial transmission chains, but also to guide outbreak control actions and/or prospective preventive measures. Here, we performed an in-depth investigation of a high-fatality rate nosocomial outbreak through the combination of vast genomic and epidemiological data to unveil routes and modes of transmission of SARS-CoV-2 within a non-COVID-19 hospital ward. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

This study describes a COVID-19 outbreak occurring in a large hospital (313 beds) from the Regional Health Administration of the Lisbon and Tagus Valley (Portugal) that employs around 1500 employees and provides healthcare assistance to around 250000 people. The outbreak occurred in a hospital ward (36 rooms, 73 beds) dedicated to internal medicine ("non-COVID-19" ward B) in Summer 2020. The epidemiological investigation covered 348 health-care workers and 92 patients. SARS-CoV-2 laboratory tests were performed on a total of 245 individuals following the international recommendations. Briefly, naso and oropharyngeal swabs were collected from patients and HCW, and RNA was subsequently extracted using m2000sp Abbott and then subjected to real-time reverse transcription PCR (RT-PCR) assay targeting using m2000rt Abbott. SARS-CoV-2 positive RNA samples were sent to the National Institute of Health (INSA) Dr. Ricardo Jorge for SARS-CoV-2 wholegenome sequencing and bioinformatics analysis.

Genome sequencing was performed at the INSA following an amplicon-based whole-genome amplification strategy using tiled, multiplexed primers, according to the ARTIC network is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

A patient attended to the emergency department of a large hospital in Portugal on Summer 2020 three days later after being discharged from the same hospital, testing positive for SARS-CoV-2 on re-admission. During the previous hospital stay (in ward A), this patient (patient 35) had had close contact with an inpatient (patient 3) from a "non-COVID-19" internal medicine ward (ward B) in a hemodialysis unit ( Figure 1) . Patient 3 and a clinician (HCW 36, working in ward B) presenting suggestive symptoms for COVID-19 were screened on the following day, also testing positive. These cases triggered a large screening of patients and HCWs in both wards ( Figure 1 ). Further testing was performed during the following days for individuals having either close contacts with positive cases or compatible symptoms. In total, no cases were detected in ward A among 51 tested individuals, whereas 27 out of 102 HCW and 21 out of 92 inpatients linked to ward B tested positive ( Figure 1 , Table 1 ). Most HCWs (all except HCWs 13, 31 and 36) were asymptomatic at the time of testing and all recovered from the infection ( Table 1) . Although most patients (n=15) were also asymptomatic at the time of testing, the mortality rate among COVID-19 patients was 57.1% (12 / 21) ( Table 1) .

An in-depth investigation was carried out to identify contacts during the 15-day period before the large screening. We collected vast data regarding HCW visits to patient's rooms, patient's room transfer and circulation to other treatment areas, which, in general, reflected a complex contact network commonly found in highly "populated" hospital wards. While HCW-patient and patient-patient contacts could be robustly traced back (Figure 1 ; Figure S1 ), the frequent is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.20.20248421 doi: medRxiv preprint contact between HCWs in common areas (inside and outside the ward B) and vast equipment/material sharing led us to assume a high likelihood of contact/transmission between all HCWs in ward B during the evaluated period. To strengthen the investigation, positive RNA samples were sent to the National Institute of Health for SARS-CoV-2 genome sequencing and analysis.

High-quality SARS-CoV-2 genome sequences were acquired from 39 positive samples, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; genetic profile (cases 1-10, green) ( Figure 2A) . Notably, all clusters enrolling identical genetic profiles included both patients and HCWs.

The integration of genomic and epidemiological data indicated that SARS-CoV-2 nosocomial dissemination was mainly driven by HCW-patient and HCW-HCW transmission ( Figure 2B ; Figure S1 ). Specifically, this scenario is supported by: i) the frequent detection of identical consensus viral sequences among HCWs and between HCW and patients contacting with each other; ii) absence of identical viral sequences in patients that shared the same room; and, iii) detection of identical viral sequences collected from patients that did not contact with each other. Indeed, patient-to-patient direct transmission was more limited, which is also corroborated by the frequent observation of one single patient testing positive in rooms with more than one patient (which occurred in eight rooms) ( Figure 2B ; Figure S1 ).

Notwithstanding, in a few cases, we found strong genetic evidence of direct patient-to-patient transmission. For instance, besides the "patient 3 -patient 35" transmission during hemodialysis, patient 20 most likely transmitted SARS-CoV-2 to patient 19 during their joint isolation (both were also infected with Clostridium difficile) ( Figure 2 ). In order to disclose intricate transmission events, we sought to verify whether mutations accumulating during the transmission chain (phylogenetic markers) were already present as minor variants (subpopulations) in samples with ascendant or identical consensus virus sequences. Remarkably, increasing frequencies were detected in three mutations (C233T, C12970T and G17478A) that turned out to fix throughout the nosocomial outbreak (Figure 2A ), For instance, the mutation G17478A (synonymous SNP in ORF1ab / NSP13) defining one of the two main branches (detected at frequencies 55.5-100.0% in that sub-cluster) was already present at a frequency of 5.5% (patient 3) and 23.7% (patient 9) in individuals presenting the viral . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. Even though, our minor variants analysis provided valuable clues about probable transmission trajectories that would be hard to disclose using solely epidemiological and consensus sequence data, especially in a scenario of a complex contact network enrolling a multitude of transmission events.

Considering that most infected individuals were detected by large screening (likely a few weeks after the virus introduction in hospital ward B), it is highly challenging to identify the "index" case of this nosocomial outbreak. According to the timeline (Figure 1 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; sequences (patients 3, 7, 8 and 9), we hypothesize that patient 3 and 8 have a higher likelihood of being the index case as they were admitted to hospital (testing negative) a few days before patients 7 and 9. In particular, patient 3 should have been infected shortly before or just after the hospital admission, as she/he most likely transmitted SARS-CoV-2 to patient 35 (his/her single contact) during hemodialysis six days later (Figures 1 and 2) . Likewise, several HCWs might have also been the index case, namely HCW 1, 2, 4, 5, 6 or 10. If one assumes that the index case is a HCW that transmitted SARS-CoV-2 to a patient with the same viral genetic profile at the beginning of the study period (namely to patient 3 or 8), we can point out HCW 2 and 6 as the most likely HCWs being the index as they visited these patients' rooms on day 2 and 3 of the study period ( Figure 2 ; Figure S1 ). In contrast, HCWs is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.20.20248421 doi: medRxiv preprint HCW or HCW-patient/patient-HCW transmission. In this context, this outbreak led to the implementation of novel measures to minimize the risk of introduction and dissemination of SARS-CoV-2 within a "non-COVID" ward. In particular, communication and educational activities were reinforced to promote compliance with standard precautions, emphasizing the need of frequent hand hygiene, maintenance of safe physical distance (1.5-2 meters) and mandatory use of respiratory protection within the ward (at least a surgical mask). Targeted and specific training events among hospital employees and visitors were carried out and further divulgation was performed through hospital intranet and website, as well as by displaying information at strategic places of the facility. Furthermore, the movement of people within the facility was limited and restricted to essential and staff break periods were recommended to be made individually. The maximum capacity of common areas, namely break rooms, HCWs changing rooms and elevators, was also reduced. Other administrative measures included changing the layout of the hospital cafeteria, with a maximum of two people allowed per table (with a distance of 1.5 meters). All HCWs and visitors were instructed about the need to wear a mask immediately after finishing meals and to avoid staying in these meal places longer than the period required. Visits to all internal medicine wards were is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

In the present study, SARS-CoV-2 genome data was key to confirm that a single introduction of SARS-CoV-2 in the non-COVID-19 ward, followed by prolonged silencing transmission, resulted in 48 infected individuals (27 HCW and 21 inpatients). As reported for other nosocomial COVID-19 outbreaks, we observed a high mortality rate (57.1%) among patients, which certainly reflects the comorbidities and demographics of the patients' population [10, 12] . The combination of vast contact tracing disclosed a complex scenario of SARS-CoV-2 transmission, consolidating the expectation that highly "populated" hospital wards, marked by extensive circulation of HCWs, pose great challenges to reconstruct direct transmission events and the exact virus spread trajectory. These challenges were even more pronounced given: i) the SARS-CoV-2 relatively low substitution rate (around one mutation every 2 weeks) (https://nextstrain.org/ncov/global), which renders identical or nearly-identical sequences in several individuals enrolled in the transmission chain; ii) that most cases were only detected upon massive screening, meaning that the viral genetic profile detected at the time of testing may not reflect the one at the time of transmission/infection; and iii) that most cases were asymptomatic at time testing, hampering any reconstruction based on the chronology of incubation period and symptoms onset. We cannot discard that mild disease symptoms might have occurred (particularly among HCWs), having been disregarded in the context of HCWs high workload and fatigue during COVID-19 crisis, as widely reported [8, 13, 23, 24] .

Notwithstanding, our results clearly demonstrated that SARS-CoV-2 dissemination within the hospital ward was mostly mediated by HCW-to-HCW and HCW-patient/patient-HCW transmission. This emphasizes the need for compliance with the current guidelines for infection prevention and control and preparedness for COVID-19 in healthcare settings, given the HCWs increased risk of virus exposure, intensive circulation within hospital facilities and close contact with frail patients [5, 6] . In the studied outbreak, as currently recommended [6] , is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.20.20248421 doi: medRxiv preprint all patients were tested upon admission to hospital and massive laboratory testing of ward residents and staff was performed after the detection of a first case. Nonetheless, the observed scenario of prolonged silencing transmission points that periodic screening of HCWs and patients, even in the absence of known cases, could have anticipated the detection of the nosocomial outbreak. Importantly, the reinforcement of control and prevention measures during and after this outbreak was shown to be effective towards the mitigation of transmission and a more timely detection and containment of novel nosocomial outbreaks.

Altogether, the present study shows the benefit of combining genomic and epidemiological data for the investigation of complex nosocomial outbreaks, while providing valuable data to minimize the risk of transmission of COVID-19 in healthcare facilities.

This study is co-funded by Fundação para a Ciência e Tecnologia and Agência de is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Data are presented as: n (%) or median (range). Symptoms: Fever, cough or shortness of breath.

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. Figure 2A) , where numbers coloured in grey indicate samples for which virus genome data could not be obtained. To facilitate the identification of patient-to-patient contact, patients timelines (rows in the figure) are grouped by room (identified by capital letters, see Figure S1 ). The hospitalization days are highlighted in light blue and the room numbers are indicated on the day a given patient was transferred to that room (the room stay extends until a new transfer appears on the timeline). With the exception of patient 35 (Ward A), all patients and room numbers are relative to Ward B. The presence in other hospital areas is also indicated when is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; relevant [Hemodialysis (Ꚛ), Emergency department ( ‡)]. The date of sample collection for healthcare workers (HCWs) testing positive is also presented at the bottom. The timeline presented starts two weeks before the large test screening and extends until the date of sample collection of the last outbreak-related positive case. Light grey fields (on both sides of the timeline) are included to show events occurring outside the study timeline. †List of HCWs with a positive test on large screening: 1, 2, 4, 5, 11, 13, 14, 17, 18, 22, 24 ,27,28,29,31,33 and 40 (no sequencing data). *, Patient admission before study period; **, Patient admission and last negative test before study period.

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Figure S1 . Timeline of HCW-patient contacts before the large screening. HCW and patient codes are colored according to the phylogenetic placement of the respective SARS-CoV-2 consensus sequences ( Figure 1A ), which exception of those without SARS-CoV-2 genome data (gray numbers in white fields). The timeline (matching that of Figure 1 , in which day 1 corresponds to the first day of the 15-day period before the large screening) summarizes the visits of infected HCWs to patient's rooms (identified by capital letters, in alphabetical order, from A to Z, followed by AA to AJ). Whenever a HCW visited a room with a patient with identical viral consensus sequence (i.e., same genetic profile), the field is colored according to the genetic profile (as in Figure 1A ) (i.e., cases with the highest likelihood of direct transmission). HD, hemodialysis. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; Figure S2 . Independent hospital introductions of SARS-CoV-2 cases after the large nosocomial outbreak led to limited transmission chains. Maximum likelihood phylogenetic tree of SARS-CoV-2 genome sequences analysed during the investigation of SARS-CoV-2 positive cases detected in a non-COVID-19 ward of a large hospital in Portugal, between August and October 2020. The tree includes viral consensus sequences analyzed during the large nosocomial outbreak (n = 40) in August (presented in the same order as in Figure 2 ), as well as 11 out of 15 new positive cases detected between 9 September and 1 October. To provide better phylogenetic context, the two closest sequences of the outbreak SARS-CoV-2 variant detected in community (Portugal/PT1550/2020, collected in 21 June 2020, and Portugal/PT1614/2020, collected in 8 July 2020; https://insaflu.insa.pt/covid19/; as of 9 November 2020) and the SARS-CoV-2 reference genome sequence (used as root; Wuhan-Hu-1/2019; MN908947.3) were also included. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.20.20248421 doi: medRxiv preprint Supplementary Table S1 . List of outbreak-related SARS-CoV-2 genome sequences generated in this study. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.20.20248421 doi: medRxiv preprint

A new coronavirus associated with human respiratory disease in China

Nosocomial outbreak of COVID-19 pneumonia in Wuhan, China

World Health Organization (WHO) Coronavirus disease (COVID-19) Weekly Epidemiological Update -08

Characteristics of SARS-CoV-2 and COVID-19

Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed. Geneva: World Health Organization

European Centre for Disease Prevention and Control. Infection prevention and control and preparedness for COVID-19 in healthcare settings -Fifth update

COVID-19: protecting health-care workers

COVID-19: the case for health-care worker screening to prevent hospital transmission

Death from Covid-19 of 23 Health Care Workers in China

Whole-genome sequencing to track SARS-CoV-2 transmission in nosocomial outbreaks

Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient

Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital

Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission

Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study

Using Virus Sequencing to Determine Source of SARS-CoV-2 Transmission for Healthcare Worker

COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study

Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples

) and the SARS-CoV-2 reference genome sequence (used as root; Wuhan-Hu-1/2019; MN908947.3) were also included. Bar graphs next to the tree depict the within-patient frequency fluctuation of three SNP phylogenetic markers (also highlighted in the respective branch) that were detected either as minor variants (<50% in frequency) or as (nearly-)fixed variants in viral populations collected from distinct infected individuals (bars are colored according to the phylogenetic placement of the respective SARS-CoV-2 consensus sequences). The SNP profile of the outbreak-related SARS-CoV-2 is provided in Supplementary Table S2. B. HCW-patient contacts occurring during the 15-day period before the large screening. HCW and patient codes are colored according to the phylogenetic placement of the respective SARS-CoV-2 consensus sequences (panel A), with exception of those without SARS-CoV-2 genome data (gray numbers in white fields). The "contact tracing matrix" summarizes the visits of

Fields are colored according to virus sequence similarity between HCW and patients, as follows: i) if a given a HCW visited a room with a patient with identical viral consensus sequence (i.e., same genetic profile), the field is colored according to the genetic profile (as in panel A) (high likelihood of direct transmission); ii) if the contact involved ascendent/descendent genetic profiles (plausible transmission) and there was no other contact with an individual with an identical virus genetic profile, the field is colored in black with a colored arrow indicating the potential direction of transmission; iii) if the contact HCW-patient is not supported by viral genetic evidence (implausible transmission), the fields are colored in gray. HD, hemodialysis. N, patients testing negative for SARS-CoV-2

Samples were obtained as part of the routine clinical care procedures of the Hospital Vila Franca de Xira. HCW and patient data were anonymized. This study is covered by the ethical approval issued by the Ethical Committee ("Comissão de Ética para a Saúde") of the Portuguese National Institute of Health.

 Table S2 . Genome background of the outbreak-related SARS-CoV-2.